Table 1 |
||||
|
Levels of estradiol and estrone in patients with diffuse cutaneous systemic sclerosis and healthy controls |
||||
|
Low |
Intermediate |
High |
Total |
|
|
|
||||
|
Estradiola |
||||
|
Controls |
14 |
20 |
1 |
35 |
|
dcSSc |
34 |
24 |
10 |
68 |
|
Total |
48 |
44 |
11 |
103 |
|
Estroneb |
||||
|
Controls |
7 |
18 |
0 |
25 |
|
dcSSc |
9 |
31 |
15 |
55 |
|
Total |
16 |
49 |
15 |
80 |
|
|
||||
|
aLow (<5 pg/ml), intermediate (5 to 10 pg/ml), and high (>10 pg/ml); P = 0.04 for controls versus diffuse cutaneous systemic sclerosis (dcSSc) using chi-square/Fisher's exact test. bLow (<15 pg/ml), intermediate (15 to 75 pg/ml), and high (>75 pg/ml); P = 0.006 for controls versus dcSSc using chi-square/Fisher's exact test. |
||||
|
Aida-Yasuoka et al. Arthritis Research & Therapy 2013 15:R10 doi:10.1186/ar4140 |
||||
